C
West Pharmaceutical Services, Inc. WST
$231.46 $1.350.59%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -16.97% -10.69% 1.20% 3.01% 1.28%
Total Depreciation and Amortization 13.18% 13.66% 15.40% 15.25% 13.85%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -96.37% 481.01% -0.20% 14.64% 103.69%
Change in Net Operating Assets 114.22% -90.79% 173.68% 29.31% -36.00%
Cash from Operations -15.85% -8.57% 6.42% 6.43% 7.25%
Capital Expenditure -4.14% -9.36% -27.43% -23.13% -27.20%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 74.63% 70.77% 87.34% -509.09% -86.11%
Cash from Investing -2.71% -7.89% -24.58% -24.90% -27.93%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -7,912.50% -8,286.96% -36.12% 94.58% 94.58%
Issuance of Common Stock -35.88% -38.30% 14.88% 48.73% 80.21%
Repurchase of Common Stock -25.58% -151.40% -143.07% -409.38% -102.97%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -3.68% -4.09% -4.12% -5.11% -5.36%
Other Financing Activities -- -100.00% -100.00% 0.00% --
Cash from Financing -35.47% -165.81% -110.86% -243.72% -56.54%
Foreign Exchange rate Adjustments -287.72% -55.74% -123.83% -368.75% 208.57%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -814.11% -340.39% -550.00% -230.15% -130.68%
Weiss Ratings